Literature DB >> 23905715

Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary.

Sultan Ahmad Halimi1, Daichi Maeda, Aya Shinozaki-Ushiku, Takahiro Koso, Keisuke Matsusaka, Mariko Tanaka, Takahide Arimoto, Katsutoshi Oda, Kei Kawana, Tetsu Yano, Tomoyuki Fujii, Masashi Fukayama.   

Abstract

AIMS: Mucinous borderline tumours of the ovary are subclassified as intestinal-type (IMBT) and endocervical-like (EMBT), which differ in their clinicopathological features. In this study, we attempted to elucidate characteristics of the mucinous epithelium in each subtype. METHODS AND
RESULTS: The expression of claudin-18, a marker of gastric differentiation, MUCs, CDX2, CK7, CK20, oestrogen receptor (ER), progesterone receptor (PgR), CA-125 and vimentin in IMBTs (n = 54), EMBTs (n = 25) and serous borderline tumours (SBTs) (n = 22) were compared by immunohistochemistry. Claudin-18 positivity was identified in 98% of the IMBTs, whereas only 4% of the EMBTs were claudin-18-positive. Expression of intestinal markers such as CDX2 and MUC2 was relatively infrequent in IMBTs (48% and 33%, respectively). Müllerian-lineage markers such as ER, PgR and vimentin were expressed rarely in IMBTs, while most EMBTs and SBTs were positive for these markers. Hierarchial clustering revealed a close association between EMBTs and SBTs, while IMBTs were clearly separate.
CONCLUSIONS: Claudin-18 positivity is a specific phenotype that is characteristic of IMBTs. Frequent and diffuse expression of gastric markers, along with less frequent and usually focal expression of intestinal markers, suggests that IMBTs are essentially composed of gastrointestinal-type mucinous epithelium (gastric-type epithelium with a variable degree of intestinal differentiation).
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  claudin-18; mucinous borderline tumour; ovary

Mesh:

Substances:

Year:  2013        PMID: 23905715     DOI: 10.1111/his.12182

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.

Authors:  Shiho Asaka; Tomoyuki Nakajima; Kaori Kugo; Risako Kashiwagi; Nozomi Yazaki; Tsutomu Miyamoto; Takeshi Uehara; Hiroyoshi Ota
Journal:  Virchows Arch       Date:  2020-01-13       Impact factor: 4.064

2.  Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.

Authors:  Shiho Asaka; Tomoyuki Nakajima; Masanobu Momose; Tsutomu Miyamoto; Takeshi Uehara; Hiroyoshi Ota
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

3.  Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status.

Authors:  Shiho Asaka; Hiroyoshi Ota; Tomoyuki Nakajima; Koichi Ida; Ryoichi Asaka; Chinatsu Kobayashi; Masayuki Ito; Tsutomu Miyamoto; Takeshi Uehara
Journal:  Virchows Arch       Date:  2021-09-28       Impact factor: 4.064

4.  Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer.

Authors:  Keisuke Matsusaka; Tetsuo Ushiku; Masayuki Urabe; Masaki Fukuyo; Hiroyuki Abe; Shumpei Ishikawa; Yasuyuki Seto; Hiroyuki Aburatani; Takao Hamakubo; Atsushi Kaneda; Masashi Fukayama
Journal:  Oncotarget       Date:  2016-09-27

5.  miR-767-3p Inhibits Growth and Migration of Lung Adenocarcinoma Cells by Regulating CLDN18.

Authors:  Yi Long Wan; Han Jue Dai; Wei Liu; Hai Tao Ma
Journal:  Oncol Res       Date:  2017-11-21       Impact factor: 5.574

Review 6.  Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics.

Authors:  Pavel Dundr; Naveena Singh; Barbora Nožičková; Kristýna Němejcová; Michaela Bártů; Ivana Stružinská
Journal:  Diagn Pathol       Date:  2021-03-11       Impact factor: 2.644

7.  Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer.

Authors:  Rachel Kerslake; Cristina Sisu; Suzana Panfilov; Marcia Hall; Nabeel Khan; Jeyarooban Jeyaneethi; Harpal Randeva; Ioannis Kyrou; Emmanouil Karteris
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.